Archives

by in
Entry Author Date Location
David Schenkein, Cancer Doc Turned CEO, Aims to Build New Genentech 10/16/13 Boston
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
Foundation Medicine Scores $106M in Upsized IPO 09/24/13 Boston
Acceleron Prices Upsized IPO at $15 Per Share, Begins Trading Thursday 09/19/13 Boston
Which VCs Are Poised to Profit From the Biotech IPO Boom? 09/09/13 National
Biotech and Fantasy Football Picks for Fall 2013 09/03/13 National
Epizyme Execs Share the Secret to a Successful IPO: PowerBars 08/15/13 Boston
East Coast Life Sciences Roundup: KiiLN, Celgene, Acceleron, & More 08/09/13 New York
Celgene Partner Acceleron Files For IPO; Plans to Raise Up to $75M 08/07/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Agios Rockets to $29 Per Share in Market Debut 07/24/13 Boston
Agios Prices Upsized IPO Above Range, Preps For Nasdaq Debut 07/24/13 Boston
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Trusting Your Partners: A Chat With Celgene’s George Golumbeski 07/11/13 New York
Bluebird Prices Ahead of Range, Takes Flight on Nasdaq Today 06/19/13 Boston
East Coast Life Sciences Roundup: Agios, Ludwig/CRI, Celgene 06/14/13 Boston
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Forma Strikes $200M Deal With Celgene to Discover Cancer Drugs 04/29/13 Boston
A Biotech Innovation Supply Chain: Reality or Fantasy? 04/22/13 National
Syros, a Whitehead and Dana-Farber Spinoff, Snags $30M For Cancer 04/11/13 Boston
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Third Rock’s Bet on Lotus Tissue Repair Generates Big Return 02/27/13 Boston
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Constant Contact, Bluefin Labs, HP, & More Boston Dealmakers 01/25/12 Boston
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Agios Pharmaceuticals Obtains $78,000,000 Series C Round 11/17/11 Boston
Page 2 of 4 « previous page · next page »